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abdominal aortic aneurysm repair in patients
with hostile and friendly neck anatomy
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Background: An increasing number of abdominal aortic aneurysms with unfavorable proximal neck anatomy are treated
with standard endograft devices. Skepticism exists with regard to the safety and efﬁcacy of this practice.
Methods: A systematic review of the literature was undertaken to identify all studies comparing the outcomes of endo-
vascular aneurysm repair (EVAR) in patients with hostile and friendly infrarenal neck anatomy. Hostile neck conditions
were deﬁned as conditions that were not consistent with the instructions for use of the endograft devices employed in the
selected studies. Outcome data were pooled, and combined overall effect sizes were calculated using ﬁxed or random
effects models.
Results: Seven observational studies reporting on 1559 patients (hostile anatomy group, 714 patients; friendly anatomy
group, 845 patients) were included. Patients with hostile anatomy required an increased number of adjunctive procedures
to achieve proximal seal compared with patients with friendly anatomy (odds ratio [OR], 3.050; 95% conﬁdence interval
[CI], 1.884-4.938). Although patients with unfavorable neck anatomy had an increased risk of developing 30-day
morbidity (OR, 2.278; 95% CI, 1.025-5.063), no signiﬁcant differences in the incidence of type I endoleak and rein-
tervention rates within 30 days of treatment between the two groups were identiﬁed (OR, 2.467 and 1.082; 95% CI,
0.562-10.823 and 0.096-12.186). Patients with hostile anatomy had a fourfold increased risk of developing type I
endoleak (OR, 4.563; 95% CI, 1.430-14.558) and a ninefold increased risk of aneurysm-related mortality within 1 year of
treatment (OR, 9.378; 95% CI, 1.595-55.137).
Conclusions: Insufﬁcient high-level evidence for or against performing standard EVAR in patients with hostile neck
anatomy exists. Our analysis suggests EVAR should be cautiously used in patients with anatomic neck constraints. (J Vasc
Surg 2013;57:527-38.)Endovascular aneurysm repair (EVAR) has been a revo-
lutionary development in the treatment of abdominal aortic
aneurysms (AAAs). The advent of endovascular technology
and the increasing experience and expertise of endovascular
specialists have had a profound impact on the management
of aortic aneurysms and resulted in improved perioperative
outcomes and late results comparable with conventionalthe Department of Vascular and Endovascular Surgery, Manchester
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the procedure, which is associated with less physiologic
insult and operative trauma, has broadened the applications
of aneurysm treatment in patients with high surgical and
anesthetic risks who were previously considered poor
surgical candidates for conventional treatment.4 However,
unfavorable morphology of the aneurysm and adverse
anatomic characteristics of the infrarenal aortic neck in
particular have restricted the widespread applicability of
EVAR and constitute the “Achilles’ heel” of the proce-
dure.5,6 Speciﬁc anatomic requirements of the proximal
aneurysm neck, such as the length and infrarenal angula-
tion, have been deﬁned by aortic endograft manufacturers
as prerequisites to ensure satisfactory long-term results.
Approximately 20% of patients with AAAs have aneu-
rysm neck morphology that is inadequate for a standard
stent graft.7 Complex endovascular procedures, such as
procedures using custom-made fenestrated endograft
systems and the chimney graft technique, have been
invented to circumvent anatomic limitations.8,9 However,527
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endovascular interventional skills, and are performed in
special tertiary vascular centers; additionally, morphologic
parameters preclude many patients from endovascular
treatment with these techniques. Numerous reports
describe difﬁculties performing conventional EVAR in
patients with aneurysms with hostile neck anatomy10-12;
conversely, an increasing number of authors have reported
successful treatment with standard endografts used in
anatomic conditions that are outside speciﬁc instructions
for use, asserting the effective applicability of EVAR in
adverse morphologies.13,14
The evolution of evidence-based medicine entails
management decisions are based on well-constructed stu-
dies and meta-analyses. The objective of the present study
was to collect and analyze all available comparative evidence
on the outcomes of EVAR in patients with hostile and
friendly neck anatomy and undertake a systematic review
and critical overview of the literature.
METHODS
Eligibility criteria. The objectives, the methodology
of the systematic review and analysis, and the inclusion
criteria for study enrollment were prespeciﬁed and docu-
mented in a protocol. Studies comparing the outcomes
of EVAR in patients with hostile and favorable infrarenal
neck anatomy were considered eligible. Generally, unfavor-
able neck conditions were deﬁned as conditions that were
not consistent with the instructions for use of the endograft
devices used in the selected studies. For a study to be
included in the analysis, it should clearly state that the
hostile group had morphologic infrarenal neck characteris-
tics that were not within the instructions for use for the
speciﬁc device (or devices) used. If no such statement
was present, potential studies should use the following
anatomic features for the deﬁnition of the hostile group
for them to be considered: neck length <15 mm (distance
between the most caudal renal artery and the origin of the
aneurysmal dilation of the aorta) and neck angulation >60
degrees (angle of intersection between lines of the long axis
of the aneurysm and the long axis of the infrarenal neck).
Other anatomic factors, which may or may not have been
considered as hostile conditions by the selected studies,
included proximal neck thrombus or calciﬁcation covering
>50% of the circumference of the aortic diameter and
a reverse taper morphology (gradual dilation of infrarenal
aorta creating a reverse conical appearance). Patients were
considered to have a hostile anatomy if one or more of
the aforementioned criteria were present on preoperative
computed tomography (CT) angiography scans. Studies
evaluating performance of stent grafts that are no longer
in use or produced by the manufacturers were not selected
for analysis. Standard endovascular techniques for the treat-
ment of AAAs were applied; patients or patient groups
treated with fenestrated or branched endograft devices or
the chimney graft technique were excluded from the anal-
ysis. Eligibility assessment of studies for inclusion in this
review was performed independently in an unblindedstandardized manner by two reviewers. Disagreements bet-
ween reviewers were arbitrated by discussion.
Deﬁnitions and end points. Outcome was expressed
by early (perioperative or within 30 days) and late primary
and secondary measures. Early primary outcome parameters
comprised technical success, perioperative morbidity and
mortality, and incidence of type I endoleak and requirement
for reintervention within 30 days of treatment. Late primary
outcome measures included aneurysm-related mortality,
incidence of type I endoleak, and need for any device-
related or aneurysm-related reintervention during the
follow-up period. Secondary outcome end points were
deﬁned as the requirement of adjunctive procedures to
achieve proximal seal, ﬂuoroscopy time, length of hospital
stay, and incidence of graft migration and conversion to
open repair at any time during follow-up. Outcome criteria
and deﬁnitions were based on recommended reporting
standards for EVAR, published by the Ad Hoc Committee
for Standardized Reporting Practices in Vascular Surgery.15
Information sources and search methods. An elec-
tronic search of the literature was undertaken. The search
was applied to MEDLINE (database provider PubMed,
from 1966 to May 2012), EMBASE (database provider
Ovid, from 1980 to May 2012), and Cochrane Central
Register of Controlled Trials (May 2012). Related articles
suggested by the PubMed search engine and reviews
on this area were searched further for additional relevant
articles. A second-level search included a manual screen
of the reference lists of selected articles identiﬁed through
the electronic search. No language constraints existed.
ExpandedMedical Subject Headings (MeSH) and key word
searches for “aortic aneurysm,” “endovascular procedures,”
“stents,” and “endoleak” and “hostile anatomy,” “hostile
aneurysm,” and “hostile neck” were combined.
Data collection and analysis. A data extraction sheet
was developed and pilot-tested on three randomly selected
included articles. Data were independently extracted
and veriﬁed by two authors. The collected variables were
divided in three broad categories: (1) baseline clinical and
demographic data, anatomic characteristics, and procedure-
related characteristics; (2) primary early and late outcome
data; and (3) secondary outcome data, as outlined previ-
ously. The methodologic quality of the included studies
was assessed according to previously described methods.
The Newcastle-Ottawa Scale (NOS) was applied to evaluate
the methodologic quality of the studies. This scale was
developed to assess the quality of studies using a “star
system” (maximum nine stars), in which a study is judged on
three broad perspectives: (1) the selection of the study
groups, (2) the comparability of the groups, and (3) the
ascertainment of outcome of interest.16
Quantitative analyses of summary statistics from the
included studies were conducted because individual patient
data were unavailable. From each study, the outcome
measures were organized in a 2  2 table to permit calcu-
lation of effect sizes for endovascular aneurysm treatment
in patients with hostile neck anatomy compared with
such treatment in patients with friendly anatomy with
Fig 1. Literature search strategy.
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incidence of type I endoleak, were transformed into
a dichotomous outcome for a speciﬁc time period (eg,
1 year). Data were extracted from the text, life tables, or
graphs. Study effects were presented using the odds ratio
(OR) in a logarithmic scale and the 95% conﬁdence interval
(CI) to describe the possible range that the pooled OR
could take; any CI that included 1 (the point of equal effect
between the two groups) was considered not to be statisti-
cally signiﬁcant. The OR and 95% CI for combined studies
were calculated using the ﬁxed effects model of meta-
analysis, unless evidence of between-study heterogeneity
existed, in which case the random effects model proposed
by DerSimonian and Laird was used.17 The Cochran
Q-test was applied to estimate between-study heteroge-
neity, and P values <.05 were considered signiﬁcant for
heterogeneity.18 For each trial, the effect by the inverse
of its standard error was plotted. Publication bias was
assessed both visually evaluating the symmetry of such fun-
nel plots and formally using the Egger regression inter-
cept.19 Sensitivity analyses were prespeciﬁed. Sensitivity
analyses were performed, and the treatment effects were
examined according to quality and type of study. The
Comprehensive Meta-Analysis software, version 2.0 (Bio-
stat, Englewood, NJ) was used for the analyses.
RESULTS
Literature search results
Eight studies met our inclusion criteria, and after
adjusting for duplicate publications, seven papers reportingon 1559 patients (hostile anatomy group, 714 patients;
friendly anatomy group, 845 patients) entered our meta-
analysis models.11–14,20–23 We identiﬁed 19 reports evalu-
ating the performance of various endograft systems in
AAAs with unfavorable infrarenal neck anatomic condi-
tions. Of these, two studies were excluded because no
control group was available with which to compare the
outcomes of the hostile population.24,25 Another two
studies were not included because although they used
neck morphologic criteria generally regarded as hostile,
neck conditions were within the instructions for use for
the Endurant (Medtronic Cardiovascular, Santa Rosa,
Calif) endograft.26,27 In ﬁve additional studies, either the
neck length or the aneurysm angulation was not used to
deﬁne the hostile anatomy, and the studies were discarded
because they did not fulﬁll our prespeciﬁed eligibility
criteria.5,6,10,28,29 Another study used mixed infrarenal
neck and iliac hostile anatomic features and was not
included in the analysis.30 An early report using an endog-
raft that is no longer in clinical use (Ancure; Guidant,
Menlo Park, Calif) was also excluded.31 Another study
reporting on treatment with obsolete stent grafts
(Fortron [Cordis, Warren, NJ], Endoﬁt [LeMaitre
Vascular, Burlington, Mass], Vanguard [Boston Scientiﬁc,
Natick, Mass], Lifepath [Edwards Lifesciences, Irvine,
Calif]) in the minority of their patients (4/147) was allowed
to remain in the analysis because these patients accounted
for 0.26% of the total meta-analysis population and were
considered to have minimal effect on the overall outcome
estimates.22 The process of report selection through litera-
ture review is outlined in a ﬂow diagram shown in Fig 1.
Table I. Study characteristics
Study NOS
Total study
population
Hostile
group
Friendly
group Deﬁnition of hostile Type of endograft
Torsello et al,13 2011 5 177 56 121 Off-label neck conditions for Endurant Endurant
AbuRahma et al,11 2010 5 238 149 89 One or more of: neck length <10 mm,
neck angulation>60, neck diameter
>28 mm, $50% circumferential
thrombus, $50% calciﬁed neck,
reverse taper
AneuRx, Excluder,
Zenith, Talent
Hoshina et al,20 2010 5 129 49 80 One or more of: neck length 15 mm,
neck angulation $60, angulation to
axis of suprarenal aorta $45
Excluder 72, Zenith 57
Abbruzzese et al,21 2008 5 565 222 343 Off-label neck conditions for Zenith,
Excluder, AneuRx
AneuRx, Zenith, Excluder
Choke et al,22 2006 6 147 60 87 One or more of: neck length <10 mm,
neck angulation>60, neck diameter
>28 mm, $50% circumferential
thrombus
Talent 65, Zenith 44,
Excluder 29, AneuRx 5,
Fortron 1, Endoﬁt 1,
Vanguard 1, Lifepath 1
Fulton et al,12 2006 3 84 25 59 One or more of: neck length <15 mm,
neck angulation >45 (off-label
conditions for AneuRx)
AneuRx
Fairman et al,14 2004 5 219 153 66 One or more of: neck length <15 mm,
neck angulation$45 (65), >50%
circumferential thrombus, >50%
calciﬁed neck
Talent
NOS, Newcastle-Ottawa Scale.
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All seven studies were either prospective or retrospective
observational studies comparing the outcomes of EVAR
in patients with adverse and favorable neck anatomies.
No randomized trials were identiﬁed. The study popula-
tion ranged from 84 to 565 patients, and the period
during which these studies were published was from
2004 to 2011. The Newcastle-Ottawa Scale for assessing
the quality of the nonrandomized studies is presented in
Table I. High scores ($6 stars) were recorded in one of
the seven observational studies included in the analysis.
Potential selection biases (poor representativeness of the
cases and selection of controls) and poorly documented
nonresponse rates (exposure category) were recorded in
most studies. The criteria used by the authors to deﬁne
the hostile group and the types of aortic endograft are
presented in Table I. Five different endografts systems
were used in most of the patients: AneuRx, Talent,
Endurant, Zenith (Cook, Bloomington, Ind), and
Excluder (Gore, Flagstaff, Ariz). Baseline demographic
and clinical data of the study populations are presented
in Table II. The outcomes of the selected study cohorts
are depicted in Table III. Most of the patients included
in this review underwent a surveillance imaging protocol
consisting of CT angiography; AbuRahma et al used
CT angiography, color duplex ultrasound scanning, or
both for follow-up surveillance.23 The CT protocol is
not consistently reported in the studies.
Synthesis of results and outcome
Adjunctive procedures. Four studies reported the
need for adjunctive procedures to achieve proximalseal.11,13,20,22 Adjunctive procedures were required in 22%
of patients with hostile anatomy and in 9% of patients with
friendly anatomy (OR, 3.050; 95% CI, 1.884-4.938; P <
.001) (Fig 2). Evidence of heterogeneity was not identiﬁed
among the studies (P ¼ .636), whereas a low possibility of
publication bias was found (P ¼ .810) (Table IV).
Technical success. Two studies reported technical
success rates.13,22 Both of them deﬁned technical success
as successful introduction and deployment of the stent
grafts in the absence of surgical conversion, type I or III
endoleak, or graft limb occlusion. Technical success was
achieved in 97% and 100% of the patients with hostile and
friendly anatomy (OR, 0.139; 95% CI, 0.015-1.275; P ¼
.081) (Fig 3). No signiﬁcant heterogeneity between the
studies was found (P ¼ .682) (Table IV).
Thirty-day mortality. Data on 30-day mortality were
reported by four studies.11,13,21,22 In the hostile anatomy
group, 30-day mortality was 2%, and in the friendly
anatomy group, 30-day mortality was likewise 2% (OR,
1.022; 95% CI, 0.419-2.493; P ¼ .962) (Fig 4). There was
no signiﬁcant heterogeneity among the studies (P ¼ .624),
and the publication bias was low (P ¼ .391) (Table IV).
Thirty-day morbidity. Two studies reported 30-day
morbidity data.11,13 In the hostile anatomy group, 30-
day morbidity was 15%, and in the friendly anatomy
group, 30-day morbidity was 7% (OR, 2.278; 95% CI,
1.025-5.063; P ¼ .043) (Fig 5). No signiﬁcant heteroge-
neity between these studies was identiﬁed (P ¼ .065)
(Table IV).
Reintervention within 30 days. The need for reinter-
vention within 30 days of treatment was reported by one
study.13 Early reintervention was required in none of the
Table II. Demographic, clinical, anatomic, and procedural characteristics of the study populations
Group
Torsello (2011) AbuRahma (2010) Hoshina (2010) Abbruzzese (2008)
Hostile
(n ¼ 56)
Friendly
(n ¼ 121)
Hostile
(n ¼ 149)
Friendly
(n ¼ 89)
Hostile
(n ¼ 49)
Friendly
(n ¼ 80)
Hostile
(n ¼ 222)
Friendly
(n ¼ 343)
Mean age, years 75 73 74 74 NR NR NR NR
Male sex (%) 48 (86) 113 (93) 118 (80) 67 (76) NR NR NR NR
HTN (%) 49 (88) 106 (88) 126 (85) 73 (82) NR NR NR NR
DM (%) 8 (14) 17 (14) 35 (23) 24 (27) NR NR NR NR
CAD (%) 29 (52) 69 (57) 86 (58) 58 (65) NR NR NR NR
Dyslipidemia (%) 28 (50) 56 (46) 86 (58) 55 (62) NR NR NR NR
CVD (%) 10 (18) 25 (21) NR NR NR NR NR NR
Smoking (%) 47 (84) 103 (85) 32 (21) 21 (24) NR NR NR NR
COPD (%) 26 (46) 57 (47) 54 (36) 27 (30) NR NR NR NR
CRF (%) 10 (18) 15 (12) 29 (19) 24 (27) NR NR NR NR
ASA III-IV (%) 50 (89) 100 (83) NR NR NR NR NR NR
Neck length (6 SD) 13.1 (8.1) 23.6 (10.2) NR NR NR NR 22.2 (11.9) 27.0 (10.7)
Neck angulation (6 SD) 60.3 (22.6) 34.6 (16.5) NR NR NR NR 46.7 (20.7) 34.6 (17.6)
Max AAA diameter
(6 SD/range)
59 (10.6) 55.9 (9.8) 61.3 (3.8-9.9) 57.9 (4.2-9.1) NR NR 57.3 (11.9) 54.5 (9.3)
Local/regional anesthesia (%) 52 (92) 116 (96) NR NR NR NR NR NR
Percutaneous EVAR (%) 55 (98) 117 (97) NR NR NR NR NR NR
Aortouniiliac device (%) 1 (2) 3 (3) NR NR NR NR NR NR
Choke (2006) Fulton (2006) Fairman (2004)
Hostile (n ¼ 60) Friendly (n ¼ 87) Hostile (n ¼ 25) Friendly (n ¼ 59) Hostile (n ¼ 153) Friendly (n ¼ 66)
74 74 NR NR NR NR
54 (90) 78 (90) NR NR NR NR
NR NR NR NR NR NR
NR NR NR NR NR NR
NR NR NR NR NR NR
NR NR NR NR NR NR
NR NR NR NR NR NR
NR NR NR NR NR NR
NR NR NR NR NR NR
NR NR NR NR NR NR
NR NR NR NR NR NR
22.6 (1.9) 29.4 (1.6) NR NR NR NR
45.9 (3.1) 27.5 (1.8) NR NR NR NR
65.3 (2) 62.7 (1.1) NR NR NR NR
NR NR NR NR NR NR
NR NR NR NR NR NR
8 (13) 7 (8) 0 (0) 0 (0) 0 (0) 0 (0)
AAA, Abdominal aortic aneurysm; ASA, American Society of Anesthesiologists; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease;
CRF, chronic renal failure; CVD, cerebrovascular disease; DM, diabetes mellitus; EVAR, endovascular aneurysm repair; HTN, hypertension; NR, not
reported; SD, standard deviation.
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with friendly anatomy (OR, 1.082; 95% CI, 0.096-12.186;
P ¼ .949) (Fig 6; Table IV).
Type I endoleak within 30 days. The incidence of
early (within 30 days of treatment) type I endoleak was re-
ported by three studies.11,13,22 These endoleaks were
detected on CT angiography 30 days after EVAR in two of
the studies13,22; AbuRahma et al11 used CT angiography
or color duplex ultrasound scan or both to examine for
endoleak 30 days after intervention. Early type I endoleak
occurred in 2% of patients with hostile neck anatomy and in
1% of patients with friendly anatomy (OR, 2.467; 95% CI,
0.562-10.823; P ¼ .232) (Fig 7). No signiﬁcant hetero-
geneity among these studies was identiﬁed (P ¼ .539), andthe possibility of publication bias was low (P ¼ .574)
(Table IV).
Type I endoleak at 1 year. Data on the incidence of
type I endoleak at 1 year were extracted from two studies.11,13
Type I endoleak occurred in 10% and 1% of the hostile and
friendly anatomy groups at 1 year (OR, 4.563; 95% CI,
1.430-14.558; P ¼ .010) (Fig 8). No signiﬁcant heteroge-
neity between these studies existed (P ¼ .271) (Table IV).
Reinterventions at 1 year. Data on device-related
reintervention at 1 year were extracted from three
studies.11,13,21 The incidence of reintervention at 1 year was
5% and 5% in the hostile and friendly anatomy groups (OR,
0.990; 95% CI, 0.547-1.792; P ¼ .974) (Fig 9). Hetero-
geneity among the studies was not signiﬁcant (P ¼ .508),
Table III. Outcomes of the study populations
Group
Torsello (2011) AbuRahma (2010) Hoshina (2010) Abbruzzese (2008)
Hostile
(n ¼ 56)
Friendly
(n ¼ 121)
Hostile
(n ¼ 149)
Friendly
(n ¼ 89)
Hostile
(n ¼ 49)
Friendly
(n ¼ 80)
Hostile
(n ¼ 222)
Friendly
(n ¼ 343)
Early outcomes
Adjunctive procedures (%) 1 (2) 0 (0) 33 (22) 8 (9) 25 (51) 16 (10) NR NR
Fluoroscopy time, minutes (range) NR NR 27 (8-81) 23 (8-70) NR NR NR NR
Technical success (%) 54 (96) 121 (100) NR NR NR NR NR NR
Hospital stay, days (6 SD/range) 4.3 (1.3) 4.3 (1.3) 4.84 (1-43) 3.95 (1-19) NR NR NR NR
30-day mortality (%) 1 (2) 2 (2) 4 (3)a 0 (0)a NR NR 4 (2) 6 (2)
30-day morbidity (%) 6 (11) 11 (9) 24 (16)a 3 (3)a NR NR NR NR
Reinterventions within 30 days (%) 0 (0) 4 (3) NR NR NR NR NR NR
Type I endoleak within 30 days (%) 2 (4) 0 (0) 1 (1) 0 (0) NR NR NR NR
Late outcomes
Type I endoleak on follow-up (%) NR NR 15 (11) 7 (8) NR NR NR NR
Type I endoleak at 1 year (%) 4 (7) 0 (0) 16 (11) 3 (3) NR NR NR NR
Reinterventions on follow-up (%) 3 (5) 1 (1) 10 (7) 5 (6) NR NR NR NR
Reinterventions at 1 year (%) 5 (9) 6 (5) 7 (5) 5 (5) NR NR 9 (4) 17 (5)
Aneurysm-related mortality on
follow-up (%)
1 (2) 0 (0) 1 (1) 0 (0) 0 (0) 0 (0) NR NR
Aneurysm-related mortality at
1 year (%)
1 (2) 0 (0) 1 (1) 0 (0) NR NR 13 (6) 0 (0)
Conversion to open repair on
follow-up (%)
0 (0) 0 (0) 0 (0) 0 (0) NR NR 3 (1) 1 (0.3)
Graft migration on follow-up (%) 0 (0) 0 (0) NR NR NR NR 3 (1) 7 (2)
Overall mortality on follow-up (%) 1 (2) 2 (2) NR NR NR NR NR NR
Choke (2006) Fulton (2006) Fairman (2004)
Hostile (n ¼ 60) Friendly (n ¼ 87) Hostile (n ¼ 25) Friendly (n ¼ 59) Hostile (n ¼ 153) Friendly (n ¼ 66)
11 (18) 9 (10) NR NR NR NR
NR NR NR NR NR NR
59 (98) 87 (100) NR NR NR NR
NR NR NR NR NR NR
2 (3) 5 (6) NR NR NR NR
NR NR NR NR NR NR
NR NR NR NR NR NR
2 (3) 2 (2) NR NR NR NR
2 (3) 1 (1) 4 (16) 3 (5) 16 (10) 10 (15)
NR NR NR NR NR NR
5 (8) 7 (8) 13 (52) 9 (15) NR NR
NR NR NR NR NR NR
NR NR 0 (0) 0 (0) NR NR
NR NR NR NR NR NR
0 (0) 0 (0) 0 (0) 0 (0) 2 (1) 4 (6)
NR NR 10 (40) 4 (7) NR NR
NR NR NR NR NR NR
NR, Not reported; SD, standard deviation.
aPerioperative data.
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(Table IV).
Aneurysm-related mortality at 1 year. Data on
aneurysm-related mortality at 1 year were extracted from
three studies.11,13,21 Aneurysm-related mortality at 1 year
occurred in 4% of the patients with hostile anatomy,
whereas no deaths occurred in the friendly anatomy group
at 1 year (OR, 9.378; 95% CI, 1.595-55.137; P ¼ .013)
(Fig 10). Heterogeneity among the studies was insigniﬁ-
cant (P ¼ .331), and the probability of publication bias was
low (P ¼ .251) (Table IV).DISCUSSION
Endovascular repair has become the mainstay treatment
modality of AAAs. Good outcomes with EVAR necessitate
assiduous and accurate planning before intervention,
focused on morphologic assessments of the proximal neck
characteristics and the aortoiliac anatomy.32 Previous series
have shown that unfavorable anatomy of the proximal aortic
neck may be responsible for 60% of patients who are
excluded from EVAR.11 The growing experience in the
application of endovascular grafts to individual patients
with AAA is reﬂected in the ﬁnding in the literature that an
Fig 2. Differences in the frequency of adjunctive procedures between the hostile and friendly anatomy groups
(A ¼ hostile anatomy group; B ¼ friendly anatomy group). CI, Conﬁdence interval.
Table IV. Summary of meta-analysis outcomes
Outcome measure Meta-analysis model OR (95% CI) P P for publication bias
Adjunctive procedures Fixed effects 3.050 (1.884-4.938) <.001 .810
Technical success Fixed effects 0.139 (0.015-1.275) .081 NA
30-day mortality Fixed effects 1.022 (0.419-2.493) .962 .391
30-day morbidity Fixed effects 2.278 (1.025-5.063) .043 NA
Reintervention within 30 days Fixed effects 1.082 (0.096-12.186) .949 NA
Type I endoleak within 30 days Fixed effects 2.467 (0.562-10.823) .232 .574
Type I endoleak at 1 year Fixed effects 4.563 (1.430-14.558) .010 NA
Reinterventions at 1 year Fixed effects 0.990 (0.547-1.792) .974 .539
Aneurysm-related mortality at 1 year Fixed effects 9.378 (1.595-55.137) .013 .251
CI, Conﬁdence interval; OR, odds ratio; NA, not applicable.
Fig 3. Differences in technical success rates between the hostile and friendly anatomy groups (A ¼ hostile anatomy
group; B ¼ friendly anatomy group). CI, Conﬁdence interval.
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characteristics and speciﬁcally patients with anatomic
features that are not consistent with the instructions for use
of endograft devices receive standard endovascular treat-
ment. Patients at signiﬁcant risk for open surgical repair
frequently have complex aortic anatomy not amenable toconventional EVAR.33 This situation has resulted in
several authors expanding the anatomic criteria that have
to be fulﬁlled before endovascular treatment is performed.
Contradictory results with regard to the outcomes of
EVAR in patients with hostile and friendly neck anatomy
exist. Our review of the literature and outcome analysis
Fig 4. Differences in 30-day mortality rates between the hostile and friendly anatomy groups (A ¼ hostile anatomy
group; B ¼ friendly anatomy group). CI, Conﬁdence interval.
Fig 5. Differences in 30-day morbidity rates between the hostile and friendly anatomy groups (A ¼ hostile anatomy
group; B ¼ friendly anatomy group). CI, Conﬁdence interval.
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provide clinicians with a base for clinical implementation
and future research.
Insufﬁcient clinical information currently exists to
provide solid evidence for or against the safety of EVAR
in patients with hostile neck anatomy. No randomized
trials investigating the potential association between
adverse morphologic neck parameters and the outcome
of endovascular treatment with standard devices were
found. Most of the existing observational studies have
low methodologic quality mainly because of patient or
control selection biases and inadequate reporting of nonre-
sponders. In addition, even though the pooled outcome
estimates are based on inclusion of seven studies in the
meta-analysis with 1559 patients, in seven of nine outcome
parameters in the meta-analysis, three or fewer of the
included studies reported relevant data and could be anal-
yzed. In none of the meta-analyses were all seven studies
included. The meta-analyses were often based on a muchsmaller number of patients than the total population
included in this review. Nevertheless, the studies selected
for analysis deﬁne the hostile group well, show adequate
comparability of the cohorts, and use acceptable methods
of ascertainment for cases and controls.
Analysis of the available data revealed comparable imme-
diate or early outcomes in the hostile and friendly anatomy
groups, as expressed by technical success, incidence of type
I endoleak, and requirement for reintervention within 30
days of treatment. Nevertheless, patients with adverse prox-
imal neck anatomy needed an increased number of adjunc-
tive procedures to achieve proximal seal, which reﬂects the
anatomic complexity and the requirement for advanced
technical expertise and increased experience of the interven-
tionalist. Such procedures included aortic cuff insertion in
most patients. Although no signiﬁcant differences in perio-
perative mortality rates between the two groups were
detected, patients with hostile neck anatomy developed peri-
operative morbidity more frequently compared with patients
Fig 6. Differences in early (within 30 days) reintervention rates between the hostile and friendly anatomy groups
(A ¼ hostile anatomy group; B ¼ friendly anatomy group). CI, Conﬁdence interval.
Fig 7. Differences in the incidence of early (within 30 days) type I endoleak between the hostile and friendly anatomy
groups (A ¼ hostile anatomy group; B ¼ friendly anatomy group). CI, Conﬁdence interval.
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might be explained by possible differences in the comorbid
status of the two groups of patients and is consistent with
previous reports showing an association between the clinical
status and the anatomic complexity of the infrarenal
aorta.30,33,34 Additionally, data from the literature conﬁrm
that patients with adverse aneurysm anatomy have higher
American Society of Anesthesiologists scores.30,35 We
presumed that all patients included in the analysis were
treated electively. However, most of the authors do not
clarify whether they treated symptomatic or asymptomatic
patients, and this creates confusion in the interpretation of
the results.
Meta-analyses of late outcome data revealed inferior
performances of standard endograft devices in patients
with hostile neck anatomy. A higher incidence of type I
endoleak at 1 year was shown in this group of patients,
whereas patients with adverse neck morphology had a nine-
fold increased risk of developing aneurysm-related
mortality within 1 year of endovascular treatment. Thisﬁnding underlines the importance of prudent patient selec-
tion and careful morphometric assessment of the aneurysm
neck before an endograft is used outside the speciﬁc
instructions for use. Although the incidence of type I
endoleak at 1 year was greater in the hostile anatomy
group, the reintervention rate was not. This indicates
that many patients with type I endoleak potentially did
not undergo reinterventions to correct the endoleak,
which may be reﬂected in the increased aneurysm-related
mortality in this group of patients over the same follow-
up period. However, the follow-up period of the selected
studies was relatively short, and no conclusions can be
reached on the comparative medium-term or long-term
performance of standard EVAR in patients’ hostile and
friendly neck features.
Aneurysm neck anatomy is an independent determi-
nant of successful positioning of an endograft and subse-
quent exclusion of the aneurysm sac. Failure to adhere to
the particular constraints of the device may compromise
the outcomes. In the European Collaborators on Stent-
Fig 9. Differences in reintervention rates at 1 year between the hostile and friendly anatomy groups (A ¼ hostile
anatomy group; B ¼ friendly anatomy group). CI, Conﬁdence interval.
Fig 8. Differences in the incidence of type I endoleak at 1 year between the hostile and friendly anatomy groups
(A ¼ hostile anatomy group; B ¼ friendly anatomy group). CI, Conﬁdence interval.
Fig 10. Differences in aneurysm-related mortality rates at 1 year between the hostile and friendly anatomy groups
(A ¼ hostile anatomy group; B ¼ friendly anatomy group). CI, Conﬁdence interval.
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STAR) database, the investigators evaluated the inﬂuence
of infrarenal neck angulation and neck length on clinical
outcomes after EVAR.5,6 Univariate and multivariate anal-
yses were applied to demonstrate a signiﬁcantly increasedrisk of proximal endoleaks at short-term and medium-term
follow-up after EVAR in patientswith short (<15mm)prox-
imal neck, whereas severe (>60 degrees) infrarenal aortic
neck angulation was found to be associated with higher inci-
dences of proximal neck dilation, proximal type I endoleak,
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devices were used, making meaningful comparisons and
the evaluation of their performances in such adverse
anatomic conditions difﬁcult. The results of the EURO-
STAR study are consistent with the results of our meta-
analysis in terms of the incidence of type I endoleak. In the
present analysis, a hostile neck anatomy was found to have
signiﬁcant effects on aneurysm-related mortality within 1
year of treatment, which may be explained by the fact that
a group of “hostile” criteria was applied by the selected
studies to assess their inﬂuence on outcomes, whereas the
EUROSTAR study evaluated the effects of single anatomic
parameters (neck length or neck angulation).
The present meta-analysis combines data across studies
to estimate treatment effects with more precision than is
possible in a single study. The main limitation is the lack of
randomized studies. The results are based on synthesis of
outcomes of observational studies, themethodologic quality
of which varied considerably. Few authors would argue that
using stent grafts outside the instructions for use might
result in increasing complications and secondary interven-
tions. The issues with all currently published studies that
analyze favorable vs unfavorable neck morphology are that
none of these studies are prospective randomized studies,
and the instructions for use are device-speciﬁc. The deﬁni-
tion of favorable vs unfavorable neck morphology is
evolving, which makes it very difﬁcult to analyze devices
with different instructions for use collectively. Our analysis
is limited by the fact that heterogeneity in the criteria used
to deﬁne hostile anatomy existed among the selected
studies. In addition, the authors used speciﬁc criteria for
“hostile neck” but did not state how many of the patients
had two or more of these qualities. Different endograft
devices with different instructions for use were used by the
authors in various study periods, which would not permit
analysis of homogeneous groups of patients and prespeciﬁed
anatomic criteria. EVAR technology and techniques have
rapidly evolved, and the newer generation of stent grafts is
designed to improve some of the failures of earlier genera-
tion stent grafts. Most operators used more than one stent
graft and under ideal circumstances chose devices that might
be best suited for a particular patient anatomy. The seven
studies analyzed in this meta-analysis all used different deﬁ-
nitions for deﬁning unfavorable aortic neck anatomy and
evaluated the outcomes in various endografts, many of
which are rarely used (eg, AneuRx, Talent) or have been
modiﬁed from earlier generation devices (eg, Zenith,
Excluder). Different devices with special characteristics
and properties, used in speciﬁc aneurysm anatomies, create
heterogeneity among the study populations examined and
may have an impact on the overall outcome estimates, which
should be considered before interpreting the results of the
present analysis.
Constant reﬁnements of aortic endograft designs have
contributed to improved results in an ever-increasing
number of patients treated with EVAR. Future research
with well-designed trials is expected to evaluate further
the possibility of applying EVAR in an expanded AAApatient population with adverse proximal neck anatomy
treated with new-generation devices. Comparisons of the
outcomes of standard EVAR vs fenestrated repair of AAA
with hostile neck anatomy may also assist clinicians with
the optimal management of these patients.
CONCLUSIONS
Insufﬁcient high-level evidence exists to demonstrate
safe use of standard EVAR in patients with hostile neck
anatomy. From the present analysis, it may be concluded
that EVAR should be used cautiously in patients with unfa-
vorable aneurysm neck anatomy. EVAR should be applied
only in patients with high surgical risk in whom all other
alternative endovascular treatments, such as fenestrated
repair, are not feasible.
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